SEC Form 4 · accession 0001179110-18-013323
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Nov 28, 2018
Accepted (ET)
Nov 30, 2018 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Nov 28, 2018 | M | 325,000 | $26.015 | A | 3,459,185 | D | |
| Common shares without par value | Nov 28, 2018 | S | 800 | $72.27 | D | 3,458,385 | D | |
| Common shares without par value | Nov 28, 2018 | S | 1,400 | $72.275 | D | 3,456,985 | D | |
| Common shares without par value | Nov 28, 2018 | S | 2,771 | $72.28 | D | 3,454,214 | D | |
| Common shares without par value | Nov 28, 2018 | S | 4,870 | $72.285 | D | 3,449,344 | D | |
| Common shares without par value | Nov 28, 2018 | S | 231 | $72.2875 | D | 3,449,113 | D | |
| Common shares without par value | Nov 28, 2018 | S | 2,102 | $72.29 | D | 3,447,011 | D | |
| Common shares without par value | Nov 28, 2018 | S | 1,327 | $72.295 | D | 3,445,684 | D | |
| Common shares without par value | Nov 28, 2018 | S | 1,381 | $72.30 | D | 3,444,303 | D | |
| Common shares without par value | Nov 28, 2018 | S | 10,757 | $72.305 | D | 3,433,546 | D | |
| Common shares without par value | Nov 28, 2018 | S | 4,385 | $72.31 | D | 3,429,161 | D | |
| Common shares without par value | Nov 28, 2018 | S | 2,300 | $72.315 | D | 3,426,861 | D | |
| Common shares without par value | Nov 28, 2018 | S | 5,100 | $72.32 | D | 3,421,761 | D | |
| Common shares without par value | Nov 28, 2018 | S | 6,945 | $72.325 | D | 3,414,816 | D | |
| Common shares without par value | Nov 28, 2018 | S | 1,595 | $72.33 | D | 3,413,221 | D | |
| Common shares without par value | Nov 28, 2018 | S | 3,460 | $72.335 | D | 3,409,761 | D | |
| Common shares without par value | Nov 28, 2018 | S | 6,825 | $72.34 | D | 3,402,936 | D | |
| Common shares without par value | Nov 28, 2018 | S | 14,290 | $72.345 | D | 3,388,646 | D | |
| Common shares without par value | Nov 28, 2018 | S | 4,250 | $72.35 | D | 3,384,396 | D | |
| Common shares without par value | Nov 28, 2018 | S | 7,181 | $72.355 | D | 3,377,215 | D | |
| Common shares without par value | Nov 28, 2018 | S | 3,800 | $72.36 | D | 3,373,415 | D | |
| Common shares without par value | Nov 28, 2018 | S | 3,008 | $72.365 | D | 3,370,407 | D | |
| Common shares without par value | Nov 28, 2018 | S | 1,916 | $72.37 | D | 3,368,491 | D | |
| Common shares without par value | Nov 28, 2018 | S | 1,761 | $72.375 | D | 3,366,730 | D | |
| Common shares without par value | Nov 28, 2018 | S | 5,200 | $72.38 | D | 3,361,530 | D | |
| Common shares without par value | Nov 28, 2018 | S | 5,462 | $72.385 | D | 3,356,068 | D | |
| Common shares without par value | Nov 28, 2018 | S | 3,100 | $72.39 | D | 3,352,968 | D | |
| Common shares without par value | Nov 28, 2018 | S | 10,022 | $72.395 | D | 3,342,946 | D | |
| Common shares without par value | Nov 28, 2018 | S | 13,564 | $72.40 | D | 3,329,382 | D | |
| Common shares without par value | Nov 28, 2018 | S | 12,538 | $72.405 | D | 3,316,844 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $26.015 | Nov 28, 2018 | M | 325,000 | D | Feb 20, 2012 | Feb 19, 2019 | Common shares | 325,000 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 1 of 3.